Updated
Updated · Bloomberg · Jun 15
Prime Radiant Invests $50 Million in Cellares as Series D Reaches $327 Million
Updated
Updated · Bloomberg · Jun 15

Prime Radiant Invests $50 Million in Cellares as Series D Reaches $327 Million

1 articles · Updated · Bloomberg · Jun 15

Summary

  • $50 million from Prime Radiant Partners will go into Cellares, the biotech robotics company, as it raises capital ahead of a potential 2027 IPO.
  • The investment adds the upstart private equity firm—founded late last year—to Cellares' Series D round, which has now gathered $327 million.
  • BlackRock, T. Rowe Price Investment Management and Ark Invest are also participating, underscoring broad backing for Cellares' push to mass-produce cancer treatments with high-tech robots.

Insights

With a 2027 IPO target, can Cellares' robotic platform truly disrupt the entire biomanufacturing industry?
Is the centralized 'Smart Factory' model the ultimate answer for scaling personalized medicine globally?